|
1
|
Lam SS, Ip CK, Mak AS and Wong AS: A novel
p70 S6 kinase-microRNA biogenesis axis mediates multicellular
spheroid formation in ovarian cancer progression. Oncotarget.
7:38064–38077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Querleu D, Meurette J, Darai E, Morice P
and Planchamp F: Surgical management of ovarian cancer: Trends in
clinical practice. Bull Cancer. 103:935–940. 2016.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wen B, Campbell KR, Tilbury K, Nadiarnykh
O, Brewer MA, Patankar M, Singh V, Eliceiri KW and Campagnola PJ:
3D texture analysis for classification of second harmonic
generation images of human ovarian cancer. Sci Rep. 6:357342016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Z, Xu S, Jin P, Yang X, Li X, Wan D,
Zhang T, Long S, Wei X, Chen G, et al: MARCKS contributes to
stromal cancer-associated fibroblast activation and facilitates
ovarian cancer metastasis. Oncotarget. 7:37649–37663.
2016.PubMed/NCBI
|
|
5
|
Correa DD, Root JC, Kryza-Lacombe M, Mehta
M, Karimi S, Hensley ML and Relkin N: Brain structure and function
in patients with ovarian cancer treated with first-line
chemotherapy: Apilot study. Brain Imaging Behav. 11:1652–1663.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomar T, de Jong S, Alkema NG, Hoekman RL,
Meersma GJ, Klip HG, van der Zee AG and Wisman GB: Genome-wide
methylation profiling of ovarian cancer patient-derived xenografts
treated with the demethylating agent decitabine identifies novel
epigenetically regulated genes and pathways. Genome Med. 8:1072016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harada T, Nakamura Y, Sato K, Nagaya T,
Okuyama S, Ogata F, Choyke PL and Kobayashi H: Near-infrared
photoimmunotherapy with galactosyl serum albumin in a model of
diffuse peritoneal disseminated ovarian cancer. Oncotarget.
7:79408–79416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Halpern JA, Shoag JE, Mittal S, Oromendia
C, Ballman KV, Hershman DL, Wright JD, Shih YT, Nguyen PL and Hu
JC: Prognostic significance of digital rectal examination and
prostate specific antigen in the prostate, lung, colorectal, and
ovarian cancer screening arm. J Urol. 197:363–368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren F, Shen J, Shi H, Hornicek FJ, Kan Q
and Duan Z: Novel mechanisms and approaches to overcome multidrug
resistance in the treatment of ovarian cancer. Biochim Biophys
Acta. 1866:266–275. 2016.PubMed/NCBI
|
|
10
|
Salerno L, Marchetti C, Bevilacqua E,
Musella A, Riganelli L, Ruscito I, Perniola G, Muzii L and Panici
Benedetti P: Beyond the beyond: First case of 9 cytoreductive
surgeries in a long-surviving ovarian cancer patient: Case report.
Tumori. 102 Suppl 2:53012016.
|
|
11
|
Matikas A, Syrigos KN and Agelaki S:
Circulating biomarkers in non-small-cell lung cancer: Current
status and future challenges. Clin Lung Cancer. 17:507–516. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Wainscott C and Xi Y: MicroRNA
provides insight into understanding esophageal cancer. Thorac
Cancer. 2:134–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giza DE, Fuentes-Mattei E, Bullock MD,
Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C and
Calin GA: Cellular and viral microRNAs in sepsis: Mechanisms of
action and clinical applications. Cell Death Differ. 23:1906–1918.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shah MY, Ferrajoli A, Sood AK,
Lopez-Berestein G and Calin GA: microRNA therapeutics in cancer -
an emerging concept. EbioMedicine. 12:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong
J and Feng J: miR-590-5p regulates gastric cancer cell growth and
chemosensitivity through RECK and the AKT/ERK pathway. Onco Targets
Ther. 9:6009–6019. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan Y, Hu H, Tan W, Jin L, Liu J and Zhou
H: MicroRNA-138 inhibits migration and invasion of non-small cell
lung cancer cells by targeting LIMK1. Mol Med Rep. 14:4422–4428.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Zhang W, Liu K, Liu S, Ji B and
Wang Y: miR-138 suppresses cell proliferation and invasion by
inhibiting SOX9 in hepatocellular carcinoma. Am J Transl Res.
8:2159–2168. 2016.PubMed/NCBI
|
|
18
|
Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z,
Liu R, Tang A, Li X, Liu F and Shen S: The tumor suppressor
miR-138-5p targets PD-L1 in colorectal cancer. Oncotarget.
7:45370–45384. 2016.PubMed/NCBI
|
|
19
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng Q, Duan P, Li L and Miao Y:
Expression of placenta growth factor is associated with unfavorable
prognosis of advanced-stage serous ovarian cancer. Tohoku J Exp
Med. 244:291–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brown RAM, Epis MR, Horsham JL, Kabir TD,
Richardson KL and Leedman PJ: Total RNA extraction from tissues for
microRNA and target gene expression analysis: Not all kits are
created equal. BMC Biotechnol. 18:162018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Paris PL, Chen J, Ngo V, Yao H,
Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, et al: Next
generation sequencing of pancreatic cyst fluid microRNAs from low
grade-benign and high grade-invasive lesions. Cancer Lett.
356:404–409. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chao A, Lai CH, Chen HC, Lin CY, Tsai CL,
Tang YH, Huang HJ, Lin CT, Chen MY, Huang KG, et al: Serum
microRNAs in clear cell carcinoma of the ovary. Taiwan J Obstet
Gynecol. 53:536–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang FF, Wang S, Xue WH and Cheng JL:
microRNA-590 suppresses the tumorigenesis and invasiveness of
non-small cell lung cancer cells by targeting ADAM9. Mol Cell
Biochem. 423:29–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sathyanarayanan A, Chandrasekaran KS and
Karunagaran D: microRNA-146a inhibits proliferation, migration and
invasion of human cervical and colorectal cancer cells. Biochem
Biophys Res Commun. 480:528–533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu Q, Gong L, Wang J, Tu Q, Yao L, Zhang
JR, Han XJ, Zhu SJ, Wang SM, Li YH and Zhang W: miR-10b exerts
oncogenic activity in human hepatocellular carcinoma cells by
targeting expression of CUB and sushi multiple domains 1 (CSMD1).
BMC Cancer. 16:8062016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagase S, Iyoda T, Kanno H, Akase T,
Arakawa I, Inoue T and Uetsuka Y: Comparison of the
cost-effectiveness of the sox and cox regimens in patients with
unresectable advanced and recurrent colorectal cancer using a
clinical decision analysis approach. Gan To Kagaku Ryoho.
43:1201–1205. 2016.(In Japanese). PubMed/NCBI
|
|
29
|
Righi S, Pileri S, Agostinelli C, Bacci F,
Spagnolo S and Sabattini E: Reproducibility of SOX-11 detection in
decalcified bone marrow tissue in mantle cell lymphoma patients.
Hum Pathol. 59:94–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fu L and Shi YB: The Sox transcriptional
factors: Functions during intestinal development in vertebrates.
Semin Cell Dev Biol. 63:58–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weina K, Wu H, Knappe N, Orouji E, Novak
D, Bernhardt M, Hüser L, Larribère L, Umansky V, Gebhardt C and
Utikal J: TGF-β induces SOX2 expression in a time-dependent manner
in human melanoma cells. Pigment Cell Melanoma Res. 29:453–458.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song WS, Yang YP, Huang CS, Lu KH, Liu WH,
Wu WW, Lee YY, Lo WL, Lee SD, Chen YW, et al: Sox2, a stemness
gene, regulates tumor-initiating and drug-resistant properties in
CD133-positive glioblastoma stem cells. J Chin Med Assoc.
79:538–545. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li N and Li S: Epigenetic inactivation of
SOX1 promotes cell migration in lung cancer. Tumour Biol.
36:4603–4610. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gambichler T, Petig AL, Stockfleth E and
Stucker M: Expression of SOX10, ABCB5 and CD271 in melanocytic
lesions and correlation with survival data of patients with
melanoma. Clin Exp Dermatol. 41:709–716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang M, Cui G, Ding M, Yang W, Liu Y, Dai
D and Chen L: miR-935 promotes gastric cancer cell proliferation by
targeting SOX7. Biomed Pharmacother. 79:153–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Mastriani E, Yan ZQ, Yin SY, Zeng
Z, Wang H, Li QH, Liu HY, Wang X, Bao HX, et al: SOX7 co-regulates
Wnt/β-catenin signaling with Axin-2: Both expressed at low levels
in breast cancer. Sci Rep. 6:261362016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding H, Quan H, Yan W and Han J: Silencing
of SOX12 by shRNA suppresses migration, invasion and proliferation
of breast cancer cells. Biosci Rep. 36:e003892016. View Article : Google Scholar
|
|
38
|
Huang W, Chen Z, Shang X, Tian D, Wang D,
Wu K, Fan D and Xia L: Sox12, a direct target of FoxQ1, promotes
hepatocellular carcinoma metastasis through up-regulating Twist1
and FGFBP1. Hepatology. 61:1920–1933. 2015. View Article : Google Scholar : PubMed/NCBI
|
